by NDNR-emmabelle-2026. | Sep 1, 2026 | September 2026: Oncology
Share This ArticleA multidisciplinary oncology case highlighting chemotherapy response, integrative recovery strategies, and long-term quality-of-life restoration. A 45-year-old woman was diagnosed with Stage II Classic Hodgkin lymphoma following a COVID-19 infection...
by NDNR-emmabelle-2026. | Jul 31, 2026 | 2026 | August
Share This ArticleJaquel Patterson, ND, MBA, FMCP-M Emerging research links pathogens such as Epstein-Barr virus, SARS-CoV-2, Lyme disease, and other infections to autoimmune disease through molecular mimicry, chronic inflammation, and...
by NDNR-emmabelle-2026. | Jul 31, 2026 | 2026 | August
Share This ArticleSaied Mushtagh, ND Patients with paresthesias and nonspecific white matter hyperintensities often present diagnostic challenges when imaging is inconclusive for multiple sclerosis. This review examines differential diagnosis, neurologic risk...
by NDNR-emmabelle-2026. | Jul 30, 2026 | 2026 | August
Share This ArticleAndrea Sulyok, ND Can patients with Hashimoto’s thyroiditis experience persistent cognitive symptoms despite normal thyroid hormone levels? This article examines the potential roles of thyroid antibodies, tissue-level T3 activity, and...
by NDNR-emmabelle-2026. | Jul 30, 2026 | 2026 | August
Share This ArticleFatima Hamade, PharmD, BCACP This case report explores the use of compounded low-dose naltrexone (LDN) as an adjunctive therapy for persistent autoimmune symptoms, highlighting its proposed immunomodulatory mechanisms, individualized dosing...
